Cancer drug therapy and stochastic modeling of "nano-motors"

about

Cancer drug therapy and stochastic modeling of "nano-motors"

Item

http://www.wikidata.org/entity/Q58563321

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cancer drug therapy and stochastic modeling of "nano-motors"

@en

Cancer drug therapy and stochastic modeling of "nano-motors"

@nl

type

Item

label

Cancer drug therapy and stochastic modeling of "nano-motors"

@en

Cancer drug therapy and stochastic modeling of "nano-motors"

@nl

prefLabel

Cancer drug therapy and stochastic modeling of "nano-motors"

@en

Cancer drug therapy and stochastic modeling of "nano-motors"

@nl

P1476

Cancer drug therapy and stochastic modeling of "nano-motors"

@en

P2093

Ayesha Sohail

http://www.w3.org/2001/XMLSchema#string

Lubna Sherin

http://www.w3.org/2001/XMLSchema#string

O Anwar Bég

http://www.w3.org/2001/XMLSchema#string

Shabieh Farwa

http://www.w3.org/2001/XMLSchema#string

Zhiwu Li

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo

Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: direct visualization in live newt lung cells

Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery

The structure of the ternary Eg5–ADP–ispinesib complex

Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5

Microtubules as a target for anticancer drugs

Analysis of the kinesin superfamily: insights into structure and function

The way things move: looking under the hood of molecular motor proteins

Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward Metastasis

In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities.

P304

6429-6440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S168780

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410329

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

bioengineering

Biofiseg

P932

6198871

http://www.w3.org/2001/XMLSchema#string